Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

ATRA Atara Biotherapeutics Inc

0,6225

0,0189 (3,13%)

Nach Börsenschluss

Zuletzt aktualisiert: 22:52:17

Verzögert um 15 Minuten

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Atara Biotherapeutics (NASDAQ:ATRA)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Atara Biotherapeutics Charts.

Atara Biotherapeutics (NASDAQ:ATRA)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Atara Biotherapeutics Charts.

News Atara Biotherapeutics Inc

Form 144 - Report of proposed sale of securities
Freitag 17 Mai 2024 (20 Stunden vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Freitag 17 Mai 2024 (20 Stunden vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Freitag 17 Mai 2024 (20 Stunden vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Freitag 17 Mai 2024 (20 Stunden vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Freitag 17 Mai 2024 (20 Stunden vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Freitag 17 Mai 2024 (21 Stunden vor) • Edgar (US Regulatory)

Form DEFR14A - Revised definitive proxy soliciting materials
Freitag 10 Mai 2024 (1 Woche vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 9 Mai 2024 (1 Woche vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 9 Mai 2024 (1 Woche vor) • Edgar (US Regulatory)

Atara Biotherapeutics Announces First Quarter 2024 Financial Results and Operational Progress
Donnerstag 9 Mai 2024 (1 Woche vor) • Business Wire

Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Freitag 3 Mai 2024 (2 Wochen vor) • Business Wire

Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Freitag 5 April 2024 (1 Monat vor) • Business Wire

Weitere Atara Biotherapeutics Inc News-Artikel

CMC Metals (QB)

Societe Generale Effekten

GlobeCoin Token

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen